TET2 and coronary artery disorder: Independent of transcriptomic profiling, TET2 CHIP status in STARNET was directly associated with greater CAD burden, including a higher number of atherosclerotic lesions (P < .001), increased CAD complexity (SYNTAX score; P < .001), and more affected coronary vessels (P < .001).